T 1716/17 (VelocImmune mouse II/REGENERON) of 10.09.2018
- European Case Law Identifier
- ECLI:EP:BA:2018:T171617.20180910
- Date of decision
- 10 September 2018
- Case number
- T 1716/17
- Online on
- 13 September 2018
- Petition for review of
- -
- Application number
- 02709544.7
- IPC class
- C12N 15/00
- Language of proceedings
- English
- Distribution
- No distribution (D)
- Download
- Decision in English
- OJ versions
- No OJ links found
- Other decisions for this case
- -
- Abstracts for this decision
- -
- Application title
- METHODS OF MODIFYING EUKARYOTIC CELLS
- Applicant name
- REGENERON PHARMACEUTICALS, INC.
- Opponent name
- Kymab Limited
Merus N.V.
Novo Nordisk A/S - Board
- 3.3.08
- Headnote
- -
- Relevant legal provisions
- European Patent Convention Art 108European Patent Convention R 99(2)European Patent Convention R 101(1)European Patent Convention R 126(2)
- Keywords
- Missing statement of grounds - admissibility of the appeal (no)
- Catchword
- -
- Cited cases
- -
- Citing cases
- -
Order
For these reasons it is decided that:
The appeal is rejected as inadmissible.